• Tech Launch Perspective
    Feb. 26, 2026

    Life sciences enterprises are under pressure to accelerate research, improve evidence generation, and operationalize AI across clinical and commercial functions. Fragmented data estates, evolving regulatory requirements, and the growing importance of real-world and genomic data are…
  • Blog
    Oct. 24, 2024

    The digital transformation landscape is rapidly evolving, and mid-market enterprises (MMEs) are emerging as significant drivers of demand.   While they may be smaller than Fortune 500 companies, MMEs are often more agile and willing to…